Key result
Basic research into HF molecular mechanisms remains essential for developing novel individualized therapies.
Why the study?
Despite many new therapies, the number of heart failure patients continues to increase and prognosis remains poor, necessitating ongoing development of new treatments based on deeper pathophysiological understanding.
Basic research into the molecular mechanisms of heart failure is essential for developing novel, personalized therapies to address the growing heart failure pandemic.
Answers are grounded in this paper and cite their sources.
Does not alter current heart failure management; leaves open whether molecular insights will enable individualized therapies.
Heart failure is caused by a variety of factors, and although many new drug and non-drug therapies have been developed for its treatment in the past decades, the number of patients with heart failure continues to increase and its prognosis is still poor. In this era, it is necessary to continue to develop new therapies. For that purpose, basic research aimed at a deeper understanding of the pathogenesis of heart failure is essential. To that end, an investigation of the ischaemia-mediated molecular mechanisms of various processes, from adaptive cardiac hypertrophy to contractile failure and DNA damage, as a cause of heart failure, has been undertaken. A novel stratification of heart failure based on comprehensive mutation and gene expression analyses has also been carried out. This article reviews the recent advances in basic heart failure research and treatment. In the future, understanding of the diversity of this disease at the molecular level is expected to lead to the development of optimal therapies that are tailored to the individual patient.
No takes yet. Share an insight, caveat, or question.
Katoh et al. (2023) conducted a review in Heart failure. Basic research into the molecular mechanisms of heart failure, including ischaemia-mediated processes and gene expression, is essential for developing novel, individualized therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: